Antiviral Platform Animation
SCIENTIFIC ANIMATION | Investor relations activities
We produced this medical animation for Cidara Therapeutics to explore their Cloudbreak® antiviral platform which is a fundamentally new approach to treating and preventing viral infections.
This mechanism of action (MoA) animation explores this technology platform and its revolutionary approach in the fight against life-threatening infectious diseases. Antiviral Fc-Conjugates (AVCs) are a new class of drugs developed from Cidara’s Cloudbreak® antiviral platform.
AVCs have the potential to prevent as well as treat influenza and other life-threatening viral diseases such as those caused by RSV, HIV, and other viral infections. These long-acting AVCs directly prevent viral proliferation whilst simultaneously engaging the immune system, maximizing viral clearance.
This animation was created for use as part of Cidara’s Investor Relations activities in order to educate potential investors on the science of this platform. Imagery and short clips from the animation have been utilized throughout their corporate presentations.
The video has been embedded onto the Cidara Therapeutics website as well as the Cidara YouTube Channel. Imagery from the animation is also found throughout the website, including an annotated image of AVC binding.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.